tm logo

Monitor this mark

View On USPTO

REGENERON
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 25 Mar 2023

Last Applicant/ Owned by

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road

Tarrytown

NY

10591

Serial Number

86921363 filed on 26th Feb 2016

Registration Number

5027241 registered on 23rd Aug 2016

in the Principal Register

Correspondent Address

Terrence J. McAllister

Terrence J. McAllister

ONE LANDMARK SQUARE

STAMFORD CT 06901

Filing Basis

1. use application currently

Disclaimer

NO DATA

REGENERON

Pharmaceutical preparations for use in the treatment of lipid metabolism disorders and hypercholesterolemia

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in the treatment of lipid metabolism disorders and hypercholesterolemia

First Use Date in General

28th Jul 2015

First Use Date in Commerce

28th Jul 2015

Mark Details

Serial Number

No 86921363

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 554.0009UST5

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
25th Mar 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
25th Mar 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
25th Mar 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Sep 2022TEAS SECTION 8 & 15 RECEIVED
14th Jul 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14th Jul 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14th Jul 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
23rd Aug 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
23rd Aug 2016REGISTERED-PRINCIPAL REGISTER
07th Jun 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED